Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Wellington Biomedical Innovation Master Investors (Cayman) II L.P.. Insider active across 6 companies, notably RayzeBio, Inc.. In total, 6 filings have been logged. Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Wellington Biomedical Innovation Master Investors (Cayman) II L.P. is a declarant linked to Metsera, Inc., Upstream Bio, Inc., MBX Biosciences, Inc., CARGO Therapeutics, Inc. and RayzeBio, Inc. The declarant has 5 filings in total. Across the 5 recent filings we hold, the period runs from 2023-09-19 to 2025-02-03, with modal transaction nature shown as C; the aggregate buy and sell amounts are both 0 EUR.